Literature DB >> 16795979

Operative morbidity and mortality after D2 and D4 extended dissection for advanced gastric cancer: a prospective randomized trial conducted by Asian surgeons.

Y Yonemura1, C C Wu, N Fukushima, I Honda, E Bandou, T Kawamura, S Kamata, H Yamamoto, B S Kim, N Matsuki, T Sawa, S H Noh.   

Abstract

BACKGROUND/AIMS: A randomized study was performed to evaluate morbidity and mortality after D2 (level 1 and 2 lymphadenectomy) and D4 (D2 plus lymphadenectomy of para-aortic lymph nodes) dissection for advanced gastric cancer.
METHODOLOGY: Two hundred and fifty-six patients with advanced gastric adenocarcinoma were enrolled (128 to each group). Patients were randomly allocated into D2 (N = 128) or D4 (N = 128) group. The first and second tiers of lymph nodes are removed in D2 dissection. In D4 gastrectomy, the paraaortic lymph nodes were additionally removed.
RESULTS: There was no indication of significant distribution bias with regard to age, sex, T-grade, and N-grade between the two groups. Operation time of D4 gastrectomy (369 +/- 120 min) was significantly longer than that of D2 gastrectomy (273 +/- 1103 min), and blood loss of the D4 group (872 +/- 683 mL) was significantly greater than that of the D2 group 571 +/- 527 mL (P < 0.001). Five (4%) and two (2%) medical complications developed in the D2 and D4 groups, respectively. Surgical complications developed in 28 (22%) and 48 patients (38%) after D2 and D4 gastrectomy. The most common complications were anastomotic leakage, pancreatic fistula, and abdominal abscess. Pancreatic fistula developed in 6 (19%) of 32 patients after D4 plus pancreatosplenectomy, but the incidence of pancreatic fistula after D2 gastrectomy plus pancreatosplenectomy was low (6%, 1/16). Two patients died within 30 days of operation (0.8%, 2/256), and each patient belonged to the D2 and D4 group.
CONCLUSIONS: Although there is a significantly higher surgical complication rate in D4 dissection, D4 dissection can be done safely as D2 dissection when performed by well-trained surgeons.

Entities:  

Mesh:

Year:  2006        PMID: 16795979

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  22 in total

1.  Dissection of No. 13 lymph node in radical gastrectomy for gastric carcinoma.

Authors:  Ding-Feng Shen; Da-Wei Chen; Zhi-Wei Quan; Ping Dong; Xue-Feng Wang; Hai-Zhou Xu; Ming-Lin Zhao; Lei Chen
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

2.  Value of nonpalliative resection as a therapeutic and pre-emptive operation for metastatic gastric cancer.

Authors:  Seong-Heum Park; Jong-Han Kim; Joong-Min Park; Sung-Soo Park; Seung-Joo Kim; Chong-Suk Kim; Young-Jae Mok
Journal:  World J Surg       Date:  2009-02       Impact factor: 3.352

3.  Survival benefit of non-curative gastrectomy for gastric cancer patients with synchronous distant metastasis.

Authors:  Chen Li; Min Yan; Jun Chen; Min Xiang; Zheng Gang Zhu; Hao Ran Yin; Yan Zheng Lin
Journal:  J Gastrointest Surg       Date:  2009-11-25       Impact factor: 3.452

Review 4.  Systematic review of D2 lymphadenectomy versus D2 with para-aortic nodal dissection for advanced gastric cancer.

Authors:  Zhen Wang; Jun-Qiang Chen; Yun-Fei Cao
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

Review 5.  Extended antimicrobial prophylaxis after gastric cancer surgery: a systematic review and meta-analysis.

Authors:  Chun-Dong Zhang; Yong-Ji Zeng; Zhen Li; Jing Chen; Hong-Wu Li; Jia-Kui Zhang; Dong-Qiu Dai
Journal:  World J Gastroenterol       Date:  2013-04-07       Impact factor: 5.742

6.  Postoperative Morbidity and Mortality Following D2 Gastrectomy-an Audit of 456 Cases.

Authors:  Bhanu Jayanand Sunil; Ramakrishnan Ayloor Seshadri; Vikash Mahajan; Hemanth Raj Ellusami
Journal:  Indian J Surg Oncol       Date:  2015-07-10

7.  Results of R0 surgery with D2 lymphadenectomy for the treatment of localised gastric cancer.

Authors:  A Díaz de Liaño; C Yárnoz; C Artieda; R Aguilar; S Viana; A Artajona; H Ortiz
Journal:  Clin Transl Oncol       Date:  2009-03       Impact factor: 3.405

8.  D2 plus para-aortic lymphadenectomy versus standardized D2 lymphadenectomy in gastric cancer surgery.

Authors:  Jian-Kun Hu; Kun Yang; Bo Zhang; Xin-Zu Chen; Zhi-Xin Chen; Jia-Ping Chen
Journal:  Surg Today       Date:  2009-03-12       Impact factor: 2.549

9.  Effect of surgical work volume on postoperative complication: superiority of specialized center in gastric cancer treatment.

Authors:  Birendra Kumar Sah; Zheng Gang Zhu; Ming Min Chen; Ming Xiang; Jun Chen; Min Yan; Yan Zhen Lin
Journal:  Langenbecks Arch Surg       Date:  2008-06-27       Impact factor: 3.445

10.  Gastric cancer surgery: Billroth I or Billroth II for distal gastrectomy?

Authors:  Birendra K Sah; Ming-Min Chen; Min Yan; Zheng-Gang Zhu
Journal:  BMC Cancer       Date:  2009-12-09       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.